Related Experiment Video
Updated: May 27, 2026
14:39
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Bronchial thermoplasty for severe asthma.
1Division of Allergy, Pulmonary, and Critical Care Medicine, Department of Medicine, Duke University Medical Center, Durham, North Carolina 27710, USA. momen.wahidi@duke.edu
American Journal of Respiratory and Critical Care Medicine
|November 15, 2011
Summary
Bronchial thermoplasty (BT) offers potential quality of life improvements for severe asthma patients, reducing exacerbations and healthcare visits. Further research is needed to confirm its broad applicability and long-term safety.
Area of Science:
- Pulmonology
- Medical Devices
- Respiratory Medicine
Background:
- Severe asthma affects patients refractory to maximal medical treatment.
- Bronchial thermoplasty (BT) is an emerging therapeutic option for severe asthma.
- BT targets airway smooth muscle reduction via thermal energy delivery.
Purpose of the Study:
- To evaluate the efficacy and safety of bronchial thermoplasty in severe asthma.
- To assess the impact of BT on quality of life and exacerbation rates.
- To determine the generalizability of BT to a wider severe asthma population.
Main Methods:
- Delivery of controlled thermal energy to airway walls during three bronchoscopies.
- Randomized controlled trials in severe asthma patients with strict inclusion/exclusion criteria.
- Assessment of airway hyperresponsiveness, FEV(1), quality of life, and exacerbation frequency.
Main Results:
- BT did not significantly reduce airway hyperresponsiveness or change FEV(1).
- BT suggested improvements in quality of life and reductions in severe exacerbations.
- Short-term adverse events included airway inflammation; long-term safety data show stability up to 5 years.
Conclusions:
- Bronchial thermoplasty may improve quality of life and reduce exacerbations in select severe asthma patients.
- Generalizability to all severe asthma patients, especially those with frequent exacerbations, requires further investigation.
- Ongoing studies are crucial for phenotyping responders, assessing durability, and confirming long-term safety.
Related Concept Videos
01:24Chest Physiotherapy
Chest Physiotherapy (CPT) is a therapeutic technique used in respiratory care to improve ventilation, clear bronchial secretions, and enhance the efficiency of respiratory muscles. This therapy includes three primary procedures: postural drainage, percussion, and vibration. It can be performed on spontaneously breathing patients and those who are intubated and mechanically ventilated.
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
Purpose
CPT is primarily used for patients with excessive bronchial secretions who have difficulty clearing...
01:26Flail Chest-II
Managing flail chest, a condition characterized by a segment of the chest wall moving independently from the rest of the thoracic cage, requires a comprehensive approach. It includes a thorough assessment of the patient's condition, a diagnostic evaluation to determine the extent of the injury, and the implementation of appropriate medical interventions tailored to the individual's needs.
Assessment:
1. Clinical Evaluation:
History:
Assessment:
1. Clinical Evaluation:
History:
01:26COPD: Management Using Bronchodilators and Corticosteroids
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
01:24Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...
01:30Asthma-IV: Diagnostic and Management
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce relaxation in these...